532 related articles for article (PubMed ID: 26001595)
1. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
[TBL] [Abstract][Full Text] [Related]
2. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model.
Wang H; Shao Y; Yuan F; Feng H; Li N; Zhang H; Wu C; Liu Z
Biomed Res Int; 2017; 2017():2503847. PubMed ID: 28691019
[TBL] [Abstract][Full Text] [Related]
3. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
[TBL] [Abstract][Full Text] [Related]
4. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
Li BH; He FP; Yang X; Chen YW; Fan JG
Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593
[TBL] [Abstract][Full Text] [Related]
5. A micro-RNA expression signature for human NAFLD progression.
Guo Y; Xiong Y; Sheng Q; Zhao S; Wattacheril J; Flynn CR
J Gastroenterol; 2016 Oct; 51(10):1022-30. PubMed ID: 26874844
[TBL] [Abstract][Full Text] [Related]
6. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
[TBL] [Abstract][Full Text] [Related]
7. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading.
Chu X; Jin Q; Chen H; Wood GC; Petrick A; Strodel W; Gabrielsen J; Benotti P; Mirshahi T; Carey DJ; Still CD; DiStefano JK; Gerhard GS
J Transl Med; 2018 Apr; 16(1):108. PubMed ID: 29690903
[TBL] [Abstract][Full Text] [Related]
8. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH.
Wang Y; Liu Z; Zou W; Hong H; Fang H; Tong W
Biomark Med; 2015; 9(11):1189-200. PubMed ID: 26506944
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
10. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
Shen Y; Cheng L; Xu M; Wang W; Wan Z; Xiong H; Guo W; Cai M; Xu F
Metabolism; 2023 Sep; 146():155657. PubMed ID: 37422021
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Petta S; Valenti L; Svegliati-Baroni G; Ruscica M; Pipitone RM; Dongiovanni P; Rychlicki C; Ferri N; Cammà C; Fracanzani AL; Pierantonelli I; Di Marco V; Meroni M; Giordano D; Grimaudo S; Maggioni M; Cabibi D; Fargion S; Craxì A
J Clin Endocrinol Metab; 2017 Aug; 102(8):2660-2669. PubMed ID: 28472477
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway.
Cai Q; Chen F; Xu F; Wang K; Zhang K; Li G; Chen J; Deng H; He Q
Metabolism; 2020 Mar; 104():154140. PubMed ID: 31926204
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity.
Li YJ; Baumert BO; Stratakis N; Goodrich JA; Wu HT; He JX; Zhao YQ; Aung MT; Wang HX; Eckel SP; Walker DI; Valvi D; La Merrill MA; Ryder JR; Inge TH; Jenkins T; Sisley S; Kohli R; Xanthakos SA; Baccarelli AA; McConnell R; Conti DV; Chatzi L
World J Gastroenterol; 2024 Jan; 30(4):332-345. PubMed ID: 38313232
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease.
Shen X; Guo H; Xu J; Wang J
J Cell Physiol; 2019 Aug; 234(10):18169-18179. PubMed ID: 30908654
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N
Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
Müller S; Raulefs S; Bruns P; Afonso-Grunz F; Plötner A; Thermann R; Jäger C; Schlitter AM; Kong B; Regel I; Roth WK; Rotter B; Hoffmeier K; Kahl G; Koch I; Theis FJ; Kleeff J; Winter P; Michalski CW
Mol Cancer; 2015 Apr; 14():94. PubMed ID: 25910082
[TBL] [Abstract][Full Text] [Related]
17. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance.
Meroni M; Longo M; Erconi V; Valenti L; Gatti S; Fracanzani AL; Dongiovanni P
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31671785
[TBL] [Abstract][Full Text] [Related]
18. Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing.
Zhang Y; Xiang D; Hu X; Ruan Q; Wang L; Bao Z
Ann Hepatol; 2020; 19(3):302-312. PubMed ID: 31899128
[TBL] [Abstract][Full Text] [Related]
19. Identification and differential expression of microRNAs associated with fat deposition in the liver of Wistar rats with nonalcoholic fatty liver disease.
Zhang D; Wang Y; Ji Z; Wang Z
Gene; 2016 Jul; 585(1):1-8. PubMed ID: 26971813
[TBL] [Abstract][Full Text] [Related]
20. Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis.
Chen Y; Huang H; Xu C; Yu C; Li Y
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28275212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
